Quality of life in dementia patients in long-term care.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMID 10679850)

Published in Int J Geriatr Psychiatry on February 01, 2000

Authors

T González-Salvador1, C G Lyketsos, A Baker, L Hovanec, C Roques, J Brandt, C Steele

Author Affiliations

1: Neuropsychiatry and Memory Group, Department of Psychiatry and Behavioral Sciences, School of Medicine, The Johns Hopkins University, Baltimore, MD 21287-5371, USA.

Articles citing this

Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry (2011) 1.50

Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol (2010) 1.05

Quality of life in nursing home residents with advanced dementia. J Am Geriatr Soc (2010) 1.04

The impact of past and present preferences on stimulus engagement in nursing home residents with dementia. Aging Ment Health (2010) 0.98

The impact of personal characteristics on engagement in nursing home residents with dementia. Int J Geriatr Psychiatry (2009) 0.94

Management of the behavioral and psychological symptoms of dementia. Clin Interv Aging (2007) 0.94

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial. Trials (2010) 0.94

Cognitive rehabilitation for elderly people with early-stage Alzheimer's disease. J Phys Ther Sci (2015) 0.93

The underlying meaning of stimuli: Impact on engagement of persons with dementia. Psychiatry Res (2010) 0.89

Physical performance and quality of life of nursing-home residents with mild and moderate dementia. Int J Environ Res Public Health (2013) 0.88

Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia. J Am Geriatr Soc (2011) 0.84

Quality of life of nursing home residents with dementia: validation of the German version of the ICECAP-O. PLoS One (2014) 0.83

APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study. Int J Geriatr Psychiatry (2008) 0.83

12-month incidence, prevalence, persistence, and treatment of mental disorders among individuals recently admitted to assisted living facilities in Maryland. Int Psychogeriatr (2013) 0.83

Resident- and Facility-Level Predictors of Quality of Life in Long-Term Care. Gerontologist (2013) 0.83

Neuropsychiatric symptoms in dementia patients with and without a history of traumatic brain injury. J Neuropsychiatry Clin Neurosci (2010) 0.82

Evaluating the Cornell Scale for Depression in Dementia as a proxy measure in nursing home residents with and without dementia. Aging Ment Health (2012) 0.79

Differences in quality of life in home-dwelling persons and nursing home residents with dementia - a cross-sectional study. BMC Geriatr (2016) 0.78

The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease. Dement Geriatr Cogn Dis Extra (2014) 0.78

Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients. Dement Geriatr Cogn Dis Extra (2015) 0.78

Positive Affect in the Midst of Distress: Implications for Role Functioning. J Community Appl Soc Psychol (2012) 0.78

Residents' perceptions of their own sadness--a qualitative study in Norwegian nursing homes. BMC Geriatr (2015) 0.77

A depressive endophenotype of mild cognitive impairment and Alzheimer's disease. PLoS One (2013) 0.77

Reliability and validity of the korean version of the cornell scale for depression in dementia. Psychiatry Investig (2012) 0.77

A Feasibility Study with Image-Based Rendered Virtual Reality in Patients with Mild Cognitive Impairment and Dementia. PLoS One (2016) 0.77

Measuring the quality of life of people with dementia in nursing homes in Germany - the study protocol for the Qol-Dem Project. Psychosoc Med (2013) 0.76

Impact of White Matter Lesions on Depression in the Patients with Alzheimer's Disease. Psychiatry Investig (2015) 0.76

Care staff and family member perspectives on quality of life in people with very severe dementia in long-term care: a cross-sectional study. Health Qual Life Outcomes (2014) 0.76

Does the care dependency of nursing home residents influence their health-related quality of life?-A cross-sectional study. Health Qual Life Outcomes (2013) 0.76

Quality of care for people with dementia. Change in attitude is needed. BMJ (2001) 0.75

Key psychosocial interventions for Alzheimer's disease: an update. Psychiatry (Edgmont) (2008) 0.75

Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2. Am J Geriatr Psychiatry (2014) 0.75

The effect of self-transcendence on depression in cognitively intact nursing home patients. ISRN Psychiatry (2012) 0.75

Major Depressive Symptoms Increase 3-Year Mortality Rate in Patients with Mild Dementia. Int J Alzheimers Dis (2017) 0.75

Depressive symptoms in later life: differential impact of social support and motivational processes on depression in individuals with and without cognitive impairment. Eur J Ageing (2014) 0.75

Articles by these authors

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med (1991) 13.91

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis (2009) 8.37

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet (2002) 6.12

The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis (2010) 5.24

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85

Landscape ecology of algal symbionts creates variation in episodes of coral bleaching. Nature (1997) 4.53

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis (2009) 4.37

Sequence and expression of human estrogen receptor complementary DNA. Science (1986) 4.36

Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet (1996) 4.20

The natural history of recovery for the healthcare provider "second victim" after adverse patient events. Qual Saf Health Care (2009) 3.79

The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg (1982) 3.65

Termination of pregnancy for maternal toxoplasmosis. Lancet (1994) 3.59

A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet (1998) 3.33

Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J (1988) 3.33

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32

Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17

The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity. Nature (2000) 2.88

Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology (2004) 2.81

Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature (2000) 2.81

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum (2003) 2.78

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr (1996) 2.77

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74

Grieving abortion loss. AWHONN Lifelines (2002) 2.66

Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol (1999) 2.65

Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology (2007) 2.56

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology (2007) 2.54

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer (1998) 2.39

A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. Int J Parasitol (2004) 2.34

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis (2004) 2.26

New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum (2003) 2.20

A 42K outer-membrane protein is a component of the yeast mitochondrial protein import site. Nature (1989) 2.18

Gamma globulin re-treatment in Kawasaki disease. J Pediatr (1993) 2.13

Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08

Vascular factors predict rate of progression in Alzheimer disease. Neurology (2007) 2.06

Atrial versus ventricular pacing in sinus node disease: a treatment comparison study. Am Heart J (1986) 2.05

Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01

Depression without sadness: functional outcomes of nondysphoric depression in later life. J Am Geriatr Soc (1997) 2.00

Time-dependent motor memory processes in amnesic subjects. J Neurophysiol (1998) 1.99

A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. Br J Psychiatry (1993) 1.98

Association between executive attention and physical functional performance in community-dwelling older women. J Gerontol B Psychol Sci Soc Sci (1999) 1.98

African Americans and high blood pressure: the role of stereotype threat. Psychol Sci (2001) 1.97

Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet (1994) 1.94

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology (1995) 1.92

Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage (2009) 1.92

APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology (2008) 1.91

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis (2006) 1.86

Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol (1992) 1.85

Self-selection in predictive testing for Huntington's disease. Am J Med Genet (1994) 1.84

Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.82

Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology (Oxford) (2005) 1.82

Quality of life in patients with Alzheimer's disease as reported by patient proxies. J Am Geriatr Soc (1996) 1.78

Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology (2006) 1.75

Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology (2004) 1.74

Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol (1996) 1.74

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol (1996) 1.74

An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr (2000) 1.73

Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone. Biochim Biophys Acta (1975) 1.73

Depressive syndromes and causal associations. Psychosomatics (1996) 1.71

The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia. J Am Geriatr Soc (1999) 1.71

Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord (2000) 1.67

HIV risk behaviors and their relationship to posttraumatic stress disorder among women prisoners. Psychiatr Serv (2001) 1.67

Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology (2006) 1.65

The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry (1997) 1.63

Epicardial right atrial free wall mapping in chronic atrial fibrillation. Documentation of repetitive activation with a focal spread--a hitherto unrecognised phenomenon in man. Eur Heart J (1997) 1.63

Fluorescence as a potential monitoring tool for recycled water systems: a review. Water Res (2008) 1.62

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology (1994) 1.61

Motor signs predict poor outcomes in Alzheimer disease. Neurology (2005) 1.60

Middle ear transmission disorders--tympanic membrane vibration analysis by laser-Doppler-vibrometry. Acta Otolaryngol (1994) 1.60

Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology (1994) 1.60

Culture of the surfaces of urinary catheters to sample urethral flora and study the effect of antimicrobial therapy. J Clin Microbiol (1985) 1.59

New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med (1999) 1.58

Infliximab treatment of severe ankylosing spondylitis: one-year followup. Arthritis Rheum (2001) 1.58

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain (1999) 1.56

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis (2004) 1.56

Is a large-scale DNA-based inventory of ancient life possible? J Hered (2005) 1.56

Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56

The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Geriatr Psychiatry (2000) 1.55

Prospective audit of multiple penetrating injuries to the colon: further support for primary closure. J R Coll Surg Edinb (1996) 1.55

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology (1994) 1.53

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis (2004) 1.53

Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis (2005) 1.51

Stress induces peroxisome biogenesis genes. EMBO J (2000) 1.51

Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology (1995) 1.50

Pyrogenicity of poly I. poly C in rabbits. Nature (1969) 1.49

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol (2008) 1.49

Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol (1988) 1.48

Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48

Conventional treatments for ankylosing spondylitis. Ann Rheum Dis (2002) 1.48

Motor signs during the course of Alzheimer disease. Neurology (2004) 1.47

A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation. Liver Transpl (2001) 1.47

Cloning and sequencing of the immunoglobulin A1 protease gene (iga) of Haemophilus influenzae serotype b. Infect Immun (1989) 1.45

Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun (2000) 1.44

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis (2007) 1.43

Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome. Thromb Haemost (2014) 1.42

Validation of recombinant Sendai virus in a non-natural host model. Gene Ther (2010) 1.42

Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect Immun (1999) 1.42